BMY vs OMDA · P/E 17, rev $24.46B vs rev $260.2M
Bristol-Myers Squibb Company (BMY) versus Omada Health, Inc. Common Stock (OMDA) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Omada Health, Inc. Common Stock (OMDA) is a health information services company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported OMDA revenue for 2025-12-31 was $260.2M. Net income was -$12.8M. Revenue was up 53.2% from 2024-12-31 to 2025-12-31. OMDA currently screens at market cap $1.03B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. OMDA currently screens at market cap $1.03B.
Not investment advice. Open the BMY and OMDA stock pages for the full models.
Not investment advice.